Wu, Hao <br/><br/>
C66 ameliorates diabetic nephropathy in mice by both upregulating NRF2 function via increase in miR-200a and inhibiting miR-21.  [electronic resource] 

 -  Diabetologia  07 2016 
 - 1558-1568 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0428 
<br/><br/><label>Standard No.: </label>10.1007/s00125-016-3958-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blood Pressure--genetics<br/>Blotting, Western<br/>Curcumin--therapeutic use<br/>Diabetes Mellitus, Experimental--drug therapy<br/>Diabetic Nephropathies--drug therapy<br/>Heterozygote<br/>Kelch-Like ECH-Associated Protein 1--genetics<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>MicroRNAs--genetics<br/>NF-E2-Related Factor 2--genetics